The Supreme Court on Monday rejected an appeal by a drug maker over a judge’s ruling that information Pfizer withheld during a Lipitor patent case was immaterial.

Ranbaxy Laboratories Ltd. had asked the justices to hear the case, which involves patents of Lipitor manufacturer Pfizer Inc. for the drug used to treat high cholesterol.